ROCKETing Forward: The Future of Atopic Dermatitis Treatment Targeting the OX40 Signalling Pathway - European Medical Journal

This site is intended for healthcare professionals

This content is intended for non-UK, US, France, Sweden, Italy or Japan based HCPs

Continue

ROCKETing Forward: The Future of Atopic Dermatitis Treatment Targeting the OX40 Signalling Pathway

Dermatology
Download PDF

This infographic summarises the data presented at the European Academy of Dermatology and Venereology (EADV) 2023 symposium, sponsored by Amgen and Kyowa Kirin.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.